Manhattan Associates Inc.

Manhattan Associates is a developer and provider of supply chain commerce solutions. The company's solutions consist of software, services, and hardware, which coordinate people, workflows, assets, events, and tasks across the functions linked in a supply chain from planning through execution. These solutions also coordinate the actions, data exchange, and communication of participants in supply chain ecosystems, such as manufacturers, suppliers, distributors, trading partners, transportation providers, channels (such as catalogers, store retailers, and Web outlets), and consumers. The company develops commerce solutions in three areas of customers' business: Supply Chain, Omnichannel and Inventory.
  • TickerMANH
  • ISINUS5627501092
  • ExchangeNASDAQ Stock Market
  • SectorSoftware & Computer Services
  • CountryUnited States

ValuEngine Rating and Forecast Report for MANH

ValuEngine Rating and Forecast Report for MANH

ValuEngine Rating and Forecast Report for MANH

ValuEngine Rating and Forecast Report for MANH

ValuEngine Rating and Forecast Report for MANH

ValuEngine Rating and Forecast Report for MANH

ValuEngine Rating and Forecast Report for MANH

ValuEngine Rating and Forecast Report for MANH

Dave Nicoski ...
  • Ross LaDuke

Vital Signs: Actionable charts

In this product we rank the most positive and negative domestic stocks, filter the symbols by market-cap and trading volume, and then divide the companies into sectors and groups. We then manually look through charts leadership/changes, bottoms-up/top-down ideas, short-term patterns that may have long-term significance, etc. We believe you will find this product valuable as significant price and relative moves begin in the daily charts.

Dave Nicoski ...
  • Ross LaDuke

Vital Signs: Actionable charts

Key Points: • A number of Financial Sector names are at or near bullish price and RS inflections. (ex. WFC, ABCB, SNV, STL, NFBK, FII, and COF) • Many Healthcare Sector names are showing leadership characteristics. (ZBH, CUTR, UHS, HCA, CHE, AMED, WST, and NEOG) • Many IT service related names remain bullish. (ex. FISV, EBOV, GPN, TSS, and EXLS)

Dave Nicoski ...
  • Ross LaDuke

Vital Signs: Actionable charts

Key Points: • A few Consumer Discretionary names continue to act well. The list is thinning of attractive names though. (ex. FOXF, UEIC, DECK, CHDN, WING, YUM, BOOT, RCI, POOL, DLTR, and AAN) • A number of Health Care Sector names are attractive. (ex. MASI, TFX, CNMD, STE, CRVL, LNTH, HAE, COO, WST, RGEN, ANIK, NEO, and TECH) • Attractive Technology and Services names include: MANH, CDNS, ANSS, AGYS, TTEC, CLGX, MMS, and KBR

Dave Nicoski ...
  • Ross LaDuke

Vital Signs: Actionable charts

Key Points: • Many Media related names are topside major bases and remains leadership. (ex. OMC, DISCA) • Auto Dealerships are showing significant strength. (ex. SAH, LAD, AN,and GPI) • Credit Card companies are staging price and RS reversals (ex. COF, and DFS) • Education stocks remains leadership and are building bases. (ex APEI, STRA, and CECO)

Dave Nicoski ...
  • Ross LaDuke

Vermilion Macro Vision: Sector Synopsis

Investors continue to prefer the stability of the U.S. relative to emerging markets. The decline in emerging markets and their currencies suggest global risk aversion. U.S. equity markets are, by contrast, not showing any significant signs of coming unhinged as a result of this rout in emerging markets. We continue to monitor the following to assess the health of the U.S. market: • U.S. Dollar: The U.S. dollar remains the de-facto world currency and has aided the U.S. equity markets in staying a step above the malaise in global markets. However we would prefer to see stabilization in emerg...

An unfavourable environment weighs on MANHATTAN ASSOCS.INCO., which sees a downgrade to Slightly Negative

The independent financial analyst theScreener just requalified the general evaluation of MANHATTAN ASSOCS.INCO. (US), active in the Software industry. As regards its fundamental valuation, the title still shows 1 out of 4 stars and its market behaviour is seen as moderately risky. theScreener believes that the unfavourable environment weighs on the sector and penalises the company, which sees a downgrade to its general evaluation to Slightly Negative. As of the analysis date March 31, 2020, the closing price was USD 49.82 and its target price was estimated at USD 47.33.

Feasibility Study Results in December to be a Catalyst for this Junior

Feasibility Study Results in December to be a Catalyst for this Junior